Search

Your search keyword '"Olivier Feron"' showing total 121 results

Search Constraints

Start Over You searched for: Author "Olivier Feron" Remove constraint Author: "Olivier Feron" Topic humans Remove constraint Topic: humans
121 results on '"Olivier Feron"'

Search Results

1. Cleaved Caspase-3 Transcriptionally Regulates Angiogenesis-Promoting Chemotherapy Resistance

2. Dealing with saturated and unsaturated fatty acid metabolism for anticancer therapy

3. Reprogramming of Energy Metabolism: Increased Expression and Roles of Pyruvate Carboxylase in Papillary Thyroid Cancer

4. Anti-alcohol abuse drug disulfiram inhibits human PHGDH via disruption of its active tetrameric form through a specific cysteine oxidation

5. Antibody-functionalized gold nanoparticles as tumor-targeting radiosensitizers for proton therapy

6. Photodynamic cancer therapy using liposomes as an advanced vesicular photosensitizer delivery system

7. Dichloroacetate Radiosensitizes Hypoxic Breast Cancer Cells

8. Cancer diets for cancer patients: Lessons from mouse studies and new insights from the study of fatty acid metabolism in tumors

9. The many metabolic sources of acetyl-CoA to support histone acetylation and influence cancer progression

10. TGFβ2-induced formation of lipid droplets supports acidosis-driven EMT and the metastatic spreading of cancer cells

11. Metabolic imaging using hyperpolarized pyruvate-lactate exchange assesses response or resistance to the EGFR inhibitor cetuximab in patient-derived HNSCC xenografts

12. Potential of memory T cells in bridging preoperative chemoradiation and immunotherapy in rectal cancer

13. Punicic Acid Triggers Ferroptotic Cell Death in Carcinoma Cells

14. Tumour acidosis: from the passenger to the driver's seat

15. Cancer cell metabolism and mitochondria: Nutrient plasticity for TCA cycle fueling

16. Re-Evaluating the Mechanism of Action of α,β-Unsaturated Carbonyl DUB Inhibitors B-AP15 and VLX1570: A Paradigmatic Example of Unspecific Protein Crosslinking with Michael Acceptor Motif-Containing Drugs

17. Exploring the Phototoxicity of Hypoxic Active Iridium(III)-Based Sensitizers in 3D Tumor Spheroids

18. Acidosis-induced metabolic reprogramming in tumor cells enhances the anti-proliferative activity of the PDK inhibitor dichloroacetate

19. Piperlongumine increases sensitivity of colorectal cancer cells to radiation: involvement of ROS production via dual inhibition of glutathione and thioredoxin systems

20. Unravelling the Allosteric Targeting of PHGDH at the ACT-Binding Domain with a Photoactivatable Diazirine Probe and Mass Spectrometry Experiments

21. Cancer heterogeneity is not compatible with one unique cancer cell metabolic map

22. Acidosis Drives the Reprogramming of Fatty Acid Metabolism in Cancer Cells through Changes in Mitochondrial and Histone Acetylation

23. Inhibition of glucose metabolism prevents glycosylation of the glutamine transporter ASCT2 and promotes compensatory LAT1 upregulation in leukemia cells

24. Cycling hypoxia

25. Inhibition of colorectal cancer-associated fibroblasts by lipid nanocapsules loaded with acriflavine or paclitaxel

26. Cycling hypoxia promotes a pro-inflammatory phenotype in macrophages via JNK/p65 signaling pathway

27. Therapeutic Potential of Focal Adhesion Kinase Inhibition in Small Cell Lung Cancer

28. Interruption of lactate uptake by inhibiting mitochondrial pyruvate transport unravels direct antitumor and radiosensitizing effects

29. A new ER-specific photosensitizer unravels 1O2-driven protein oxidation and inhibition of deubiquitinases as a generic mechanism for cancer PDT

30. Reducing the serine availability complements the inhibition of the glutamine metabolism to block leukemia cell growth

31. Intracellular siRNA delivery dynamics of integrin-targeted, PEGylated chitosan–poly(ethylene imine) hybrid nanoparticles: A mechanistic insight

32. Metabolic and mind shifts

33. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

34. Emerging roles of lipid metabolism in cancer progression

35. α-Ketothioamide Derivatives: A Promising Tool to Interrogate Phosphoglycerate Dehydrogenase (PHGDH)

36. The NLRP3 Inflammasome Has a Critical Role in Peritoneal Dialysis-Related Peritonitis

37. Vitamin E-based micelles enhance the anticancer activity of doxorubicin

38. The SIRT1/HIF2α Axis Drives Reductive Glutamine Metabolism under Chronic Acidosis and Alters Tumor Response to Therapy

39. Hypoxia Modulates the Differentiation Potential of Stem Cells of the Apical Papilla

40. Reprogramming of tumor metabolism by targeting mitochondria improves tumor response to irradiation

41. Tumour hypoxia determines the potential of combining mTOR and autophagy inhibitors to treat mammary tumours

42. PTEN deficiency is associated with reduced sensitivity to mTOR inhibitor in human bladder cancer through the unhampered feedback loop driving PI3K/Akt activation

43. Challenges and Opportunities in the Development of Serine Synthetic Pathway Inhibitors for Cancer Therapy

44. Multimodality imaging identifies distinct metabolic profiles in vitro and in vivo

45. Phase II study of everolimus in patients with locally advanced or metastatic transitional cell carcinoma of the urothelial tract: clinical activity, molecular response, and biomarkers

46. Vascular Hypoxic Preconditioning Relies on TRPV4-Dependent Calcium Influx and Proper Intercellular Gap Junctions Communication

47. LDV peptidomimetics equipped with biotinylated spacer-arms: Synthesis and biological evaluation on CCRF-CEM cell line

48. Lactate shuttles at a glance: from physiological paradigms to anti-cancer treatments

49. Preconditioned Endothelial Progenitor Cells Reduce Formation of Melanoma Metastases through SPARC-Driven Cell–Cell Interactions and Endocytosis

50. Surface properties and cell adhesion onto allylamine-plasma and amine-plasma coated glass coverslips

Catalog

Books, media, physical & digital resources